1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ACADIA PHARMACEUTICALS INC
Acadia Pharmaceuticals Inc XNAS: ACAD

Acadia Pharma Inc Live Stock Price Today, Share Analysis and Chart

Mid-range Performer
about

Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has two core franchises in neuros...

Read More
26.84 -0.67 (-2.44%)
100.30% Gain from 52W Low
2.0M
XNAS Volume

XNAS 23 Jan, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert
Durability score
High Financial Strength
55.6 / 100
Valuation Score
Mid Valuation
47.2 / 100
Momentum Score
Technically Neutral
59.4 / 100
Mid-range Performer These stocks have strong quality. Their reasonable financials and technicals make them potentially attractive to investors View Similar Embed DVM
Analyst Price Target
31
1Yr Price target upside is 15%
19 analysts

23

S

4

W

3

O

1

T

SWOT Analysis

Acadia Pharma Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..